Real World Practice With Academic Anti CD19 CAR-T Cell Therapy in Relapse/Refractory B-cell Lymphoma

Clinical trial NCT07524816 · RECRUITING

Trial details

NCT number: NCT07524816
Sponsor: N.N. Alexandrov National Cancer Centre
Status: RECRUITING
Study type: OBSERVATIONAL

Large B-Cell Lymphoma (LBCL)

Start date: 2021-06-01
Primary completion: 2028-01-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.